Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're in Manchester and researching weight loss injections, the short answer is this: Mounjaro (tirzepatide) and Wegovy (semaglutide) are both licensed in the UK for weight management, available to eligible adults via private prescription, and can be dispensed by a GPhC-registered online pharmacy and delivered to any Manchester address — no clinic appointment, no travel required. Both are prescription-only medicines, meaning a qualified prescriber has to assess your suitability before anything is dispensed. That clinical step isn't a formality; it's the part that keeps the whole thing safe.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've spent time looking into weight loss injections and you've seen a range of prices, a lot of bold claims and not much detail about what the process genuinely involves. That's where most people in Manchester are when they first reach out. The reality is quieter than the marketing suggests. You fill in a consultation, medical history, current weight, relevant conditions. A prescriber (a real person, GPhC-registered, not software) reads it the same day. If you're clinically suitable, a prescription is issued and your treatment is dispensed from a UK pharmacy. The pen arrives via DPD the next working day, tracked to your door, in plain packaging with nothing on the outside to indicate what's inside.
That's the legal, regulated route. The medicines themselves (Mounjaro and Wegovy) are subcutaneous injections, meaning a very fine needle goes just under the skin of your abdomen, thigh or upper arm once a week. Most people manage this without much difficulty after the first attempt. Our guide to weight loss injections covers the practical side in more detail, including what to expect on injection day.
The NHS version of this pathway exists too, but access is phased by BMI and comorbidities, and waiting lists in Manchester as elsewhere can be long. If you're based elsewhere in the country, we also serve people looking into weight loss injections in Doncaster, where the same regulated process applies. Private treatment through a regulated pharmacy is the parallel route for people who don't meet the current NHS criteria or simply don't want to wait.
Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't guarantee approval, a prescriber weighs the full clinical picture, including any contraindications.
Mounjaro works on two gut-hormone receptors (GIP and GLP-1), making it the only dual-agonist weight-loss medicine licensed in the UK. Treatment starts at 2.5mg, which exists to let your body adjust rather than as a therapeutic dose, and is titrated upward by your prescriber in roughly four-week steps. Wegovy targets the GLP-1 receptor only and follows a similar escalation pattern, with a standard maintenance dose of 2.4mg weekly; the MHRA also approved a higher 7.2mg dose in early 2026. The NHS medicines page on tirzepatide and the equivalent semaglutide page are good plain-English starting points for understanding how each works and what side effects to expect.
If you're comparing the two, our weight loss injections overview sets out the evidence side by side. The short version: tirzepatide tends to produce greater average weight reduction in trials, including in the 2025 SURMOUNT-5 head-to-head study published in the New England Journal of Medicine, but which suits you is a clinical question, not a marketing one.
The most common side effects with both medicines are gastrointestinal: nausea, loose stools, constipation, indigestion, and occasionally vomiting, particularly in the first few days after a new or increased dose. These usually settle. Eating smaller portions, avoiding rich or fatty meals and staying well hydrated helps most people through the adjustment. Fatigue and mild headaches are also reported, especially early on.
One side effect that warrants immediate medical attention is severe stomach pain that extends to the back, this can be a sign of pancreatitis, a known but infrequent risk flagged in a January 2026 MHRA Drug Safety Update covering GLP-1 medicines. Don't wait if the pain is severe or persistent. The Yellow Card scheme lets you report any suspected reaction, and it also has a route for flagging suspect sellers, relevant given the volume of counterfeit pens circulating online.
On the practical side: pens are stored in the fridge at 2–8°C. Needles are single-use and should be disposed of in a dedicated sharps container rather than the general bin, a 1-litre sharps container is a sensible addition to your kit. Rotate your injection site weekly to avoid skin changes at the same spot. Women using oral contraceptives alongside tirzepatide should discuss contraception with their prescriber, as absorption of the pill may be affected in the first weeks of treatment and after each dose increase.
You don't need a referral or a Manchester-based clinic to access these medicines legally. A regulated online pharmacy that holds a GPhC premises registration can prescribe and dispense to any UK address, including Greater Manchester, after a proper clinical consultation. You can check any online pharmacy's registration on the GPhC register, it takes about thirty seconds and is worth doing before you hand over any personal details.
Red flags to watch for: websites offering these medicines without a clinical assessment, social media sellers, prices that sit well below the private market (Eli Lilly raised Mounjaro's UK list price significantly in September 2025, and typical private prices since then range roughly £149–£375 per month depending on dose and provider), and anyone dangling discount codes for a prescription medicine. The MHRA has seized approximately 20 million doses of illegally traded weight-loss medicines worth around £45 million, and in October 2025 raided the first UK site manufacturing counterfeit tirzepatide pens. That context matters when you're comparing prices online. Our guide to buying weight loss injections explains what legitimate supply looks like in more detail.
For a broader look at treatment options beyond the injections, our weight loss treatment overview covers everything from oral semaglutide to orlistat, and if you're in the West Midlands you can find area-specific information on our page covering weight loss injections in Worcester. We also have dedicated guidance for people exploring weight loss injections in Colchester, where the same clinical process and overnight delivery apply. When you're ready to talk to a prescriber, check your eligibility with a free consultation, our clinical team reviews every application the same day it arrives.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.